120 related articles for article (PubMed ID: 8208061)
1. Neurokinin receptor subtypes characterized by biological assays.
Regoli D; Nguyen QT; Jukic D
Life Sci; 1994; 54(26):2035-47. PubMed ID: 8208061
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of neurokinin receptors with agonists and antagonists.
Regoli D; Nguyen QT; Jukic D; Rouissi N
Regul Pept; 1993 Jul; 46(1-2):287-9. PubMed ID: 7692518
[No Abstract] [Full Text] [Related]
3. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor.
Nguyen-Le XK; Nguyen QT; Gobeil F; Pheng LH; Emonds-Alt X; Brelière JC; Regoli D
Pharmacology; 1996 May; 52(5):283-91. PubMed ID: 8807672
[TBL] [Abstract][Full Text] [Related]
4. Two NK-3 receptor subtypes: demonstration by biological and binding assays.
Nguyen QT; Jukic D; Chrétien L; Gobeil F; Boussougou M; Regoli D
Neuropeptides; 1994 Sep; 27(3):157-61. PubMed ID: 7529376
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
[TBL] [Abstract][Full Text] [Related]
6. A potent and selective agonist for NK-2 tachykinin receptor.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin receptor assays.
Meini S; Maggi CA
Curr Protoc Pharmacol; 2010 Mar; Chapter 4():Unit 4.10. PubMed ID: 22294370
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin receptor types and B2 subtypes.
Regoli D; Gobeil F; Nguyen QT; Jukic D; Seoane PR; Salvino JM; Sawutz DG
Life Sci; 1994; 55(10):735-49. PubMed ID: 8072371
[TBL] [Abstract][Full Text] [Related]
11. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
[TBL] [Abstract][Full Text] [Related]
14. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
15. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
Hall JM; Flowers JM; Morton IK
Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
[TBL] [Abstract][Full Text] [Related]
16. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
17. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Feng DM; Folkers K
Eur J Pharmacol; 1991 Jun; 199(1):127-9. PubMed ID: 1716573
[TBL] [Abstract][Full Text] [Related]
18. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
19. Characterization of neurokinin receptors in various isolated organs by the use of selective agonists.
Dion S; D'Orléans-Juste P; Drapeau G; Rhaleb NE; Rouissi N; Tousignant C; Regoli D
Life Sci; 1987 Nov; 41(20):2269-78. PubMed ID: 2824947
[TBL] [Abstract][Full Text] [Related]
20. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]